Avalo Therapeutics (AVTX) Stock Chart & Stock Price History $5.80 -0.79 (-11.99%) Closing price 04:00 PM EasternExtended Trading$5.88 +0.09 (+1.47%) As of 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics Stock Price Performance 5 Day Performance-33.22%1 Month Performance-18.12%3 Month Performance-32.66%6 Month Performance-42.17%Year-To-Date Performance-23.96%1 Year Performance-65.34% Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTX Stock Chart for Friday, April, 4, 2025 AVTX Chart by TradingViewRemove Ads Avalo Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/03/2025$7.08$6.59-6.92%$7.00$6.4041,242 shs$70.33 million04/02/2025$6.85$7.08+3.36%$7.41$6.9825,631 shs$75.56 million04/01/2025$8.01$6.85-14.48%$8.37$6.8128,215 shs$73.10 million03/31/2025$8.46$8.01-5.32%$8.46$7.7239,379 shs$85.48 million03/28/2025$8.73$8.46-3.09%$8.90$8.1636,738 shs$90.29 million03/27/2025$8.36$8.73+4.43%$9.00$7.8883,026 shs$93.17 million03/26/2025$8.54$8.36-2.11%$8.99$8.0434,995 shs$89.22 million03/25/2025$7.63$8.54+11.93%$9.70$8.14300,368 shs$88.77 million03/24/2025$7.66$7.63-0.39%$7.63$6.9819,351 shs$79.31 million03/21/2025$8.22$7.66-6.81%$8.19$7.4733,867 shs$79.62 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/20/2025$7.99$8.22+2.88%$8.30$7.6527,610 shs$85.44 million03/19/2025$7.77$7.99+2.83%$8.00$7.608,115 shs$83.05 million03/18/2025$7.69$7.77+1.04%$7.88$7.2825,787 shs$80.76 million03/17/2025$7.39$7.69+4.06%$7.80$7.0634,509 shs$79.93 million03/14/2025$7.42$7.39-0.40%$7.56$7.0936,384 shs$76.81 million03/13/2025$7.70$7.42-3.64%$7.98$7.2133,376 shs$77.12 million03/12/2025$7.99$7.70-3.63%$8.11$7.4127,189 shs$80.03 million03/11/2025$7.19$7.99+11.13%$8.40$7.071.23 million shs$83.05 million03/10/2025$7.76$7.19-7.35%$8.25$7.0143,390 shs$74.73 million03/07/2025$7.33$7.76+5.87%$8.90$7.00124,912 shs$80.66 million03/06/2025$6.98$7.33+5.01%$7.71$6.8321,699 shs$76.19 million03/05/2025$6.90$6.98+1.16%$7.17$6.4829,218 shs$72.55 million03/04/2025$6.70$6.90+2.99%$7.28$6.3824,907 shs$71.72 million03/03/2025$7.31$6.70-8.34%$7.31$6.5525,774 shs$69.64 million Related Companies Cartesian Therapeutics Stock Chart Entrada Therapeutics Stock Chart Heron Therapeutics Stock Chart Ginkgo Bioworks Stock Chart Tectonic Therapeutic Stock Chart Allogene Therapeutics Stock Chart Amylyx Pharmaceuticals Stock Chart Benitec Biopharma Stock Chart Cryoport Stock Chart Astria Therapeutics Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVTX Stock Free AVTX Stock Alerts